Management of ICP involves both symptomatic relief and measures to reduce bile acid levels. Medications such as ursodeoxycholic acid (UDCA) are commonly prescribed to improve bile flow and alleviate itching. Regular monitoring of bile acid levels and liver function tests is essential. In some cases, early delivery may be considered to reduce risks to the fetus, particularly if bile acid levels are significantly elevated.
